Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a predominant chronic liver condition globally, intricately linked with obesity, type 2 diabetes (T2DM), and metabolic syndrome.
Understanding leptin’s dual function in MAFLD pathogenesis
- Post author:admin
- Post published:November 14, 2025
- Post category:uncategorized